← Insider buys
ALLO

Allogene Therapeutics, Inc. · Healthcare

Chief Technical Officer Alison Moore sold $1.8M of Allogene Therapeutics, Inc.

Sold$1,827,534
$41.00Price
44,574Shares
−29%Stake

What ALLO did after the filing

Prices for ALLO after this filing aren't in yet.

Traded Thu, Oct 8. Filed Fri, Oct 9, 1:49 PM ET, during the session. Not investment advice.